Literature DB >> 20072728

Histone deacetylases as targets for the treatment of human neurodegenerative diseases.

Santosh R D'Mello1.   

Abstract

Histone deacetylases (HDACs) are a family of proteins that play an important role in regulating transcription as well as the function of a variety of cellular proteins. While these proteins are expressed abundantly in the brain, little is known about their roles in brain function. A growing body of evidence suggests that HDACs regulate neuronal survival. Results from studies conducted in vertebrate and mammalian experimental systems indicate that while some of these proteins are involved in promoting neuronal death, a majority of the HDACs studied thus far protect against neurodegeneration. Here we review the research performed on the role played by individual members of the HDAC family in the regulation of neuronal death. Chemical inhibitors of HDACs have been used in a variety of models of neurodegenerative disorders. We summarize the results from these studies, which indicate that HDAC inhibitors show great promise as therapeutic agents for human neurodegenerative disorders. Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20072728      PMCID: PMC3934413          DOI: 10.1358/dnp.2009.9.1428871

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  124 in total

Review 1.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

2.  Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.

Authors:  Brett Langley; Melissa A D'Annibale; Kyungsun Suh; Issam Ayoub; Aaron Tolhurst; Birgül Bastan; Lichuan Yang; Brian Ko; Marc Fisher; Sunghee Cho; M Flint Beal; Rajiv R Ratan
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

Review 3.  Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

Authors:  Ted Abel; R Suzanne Zukin
Journal:  Curr Opin Pharmacol       Date:  2008-02       Impact factor: 5.547

4.  Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.

Authors:  David B Lombard; Frederick W Alt; Hwei-Ling Cheng; Jakob Bunkenborg; Ryan S Streeper; Raul Mostoslavsky; Jennifer Kim; George Yancopoulos; David Valenzuela; Andrew Murphy; Yinhua Yang; Yaohui Chen; Matthew D Hirschey; Roderick T Bronson; Marcia Haigis; Leonard P Guarente; Robert V Farese; Sherman Weissman; Eric Verdin; Bjoern Schwer
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

5.  Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice.

Authors:  Olesya Vakhrusheva; Christian Smolka; Praveen Gajawada; Sawa Kostin; Thomas Boettger; Thomas Kubin; Thomas Braun; Eva Bober
Journal:  Circ Res       Date:  2008-01-31       Impact factor: 17.367

6.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.

Authors:  Eriko Michishita; Ronald A McCord; Elisabeth Berber; Mitomu Kioi; Hesed Padilla-Nash; Mara Damian; Peggie Cheung; Rika Kusumoto; Tiara L A Kawahara; J Carl Barrett; Howard Y Chang; Vilhelm A Bohr; Thomas Ried; Or Gozani; Katrin F Chua
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

Review 7.  Inhibitors of NAD+ dependent histone deacetylases (sirtuins).

Authors:  Robert C Neugebauer; Wolfgang Sippl; Manfred Jung
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.

Authors:  Yu Zhang; Sohee Kwon; Teppei Yamaguchi; Fabien Cubizolles; Sophie Rousseaux; Michaela Kneissel; Chun Cao; Na Li; Hwei-Ling Cheng; Katrin Chua; David Lombard; Adam Mizeracki; Gabriele Matthias; Frederick W Alt; Saadi Khochbin; Patrick Matthias
Journal:  Mol Cell Biol       Date:  2008-01-07       Impact factor: 4.272

9.  Localization of mouse mitochondrial SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5.

Authors:  Yasuhiko Nakamura; Masahito Ogura; Daisuke Tanaka; Nobuya Inagaki
Journal:  Biochem Biophys Res Commun       Date:  2007-12-03       Impact factor: 3.575

10.  The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.

Authors:  Ruwin Pandithage; Richard Lilischkis; Kai Harting; Alexandra Wolf; Britta Jedamzik; Juliane Lüscher-Firzlaff; Jörg Vervoorts; Edwin Lasonder; Elisabeth Kremmer; Bernd Knöll; Bernhard Lüscher
Journal:  J Cell Biol       Date:  2008-03-10       Impact factor: 10.539

View more
  26 in total

Review 1.  Epigenetic mechanisms in memory and synaptic function.

Authors:  Faraz A Sultan; Jeremy J Day
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

2.  Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta.

Authors:  Farah H Bardai; Santosh R D'Mello
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 3.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

4.  Conditional deletion of histone deacetylase-4 in the central nervous system has no major effect on brain architecture or neuronal viability.

Authors:  Valerie Price; Lulu Wang; Santosh R D'Mello
Journal:  J Neurosci Res       Date:  2012-12-14       Impact factor: 4.164

5.  Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.

Authors:  Huajun Jin; Arthi Kanthasamy; Dilshan S Harischandra; Naveen Kondru; Anamitra Ghosh; Nikhil Panicker; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

6.  Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA).

Authors:  Marisela Agudelo; Nimisha Gandhi; Zainulabedin Saiyed; Vijaya Pichili; Samikkannu Thangavel; Pradnya Khatavkar; Adriana Yndart-Arias; Madhavan Nair
Journal:  Alcohol Clin Exp Res       Date:  2011-03-29       Impact factor: 3.455

7.  HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides.

Authors:  Carol Ann Castañeda; Noah A Wolfson; Katherine R Leng; Yin-Ming Kuo; Andrew J Andrews; Carol A Fierke
Journal:  J Biol Chem       Date:  2017-11-06       Impact factor: 5.157

Review 8.  Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries.

Authors:  Sheng Chen; Haijian Wu; Damon Klebe; Yuan Hong; Jianmin Zhang
Journal:  Neurochem Res       Date:  2014-01-31       Impact factor: 3.996

9.  Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism.

Authors:  Chi Ma; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

10.  Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death.

Authors:  Farah H Bardai; Valerie Price; Marcus Zaayman; Lulu Wang; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2012-08-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.